Hilbi Hubert, Jozsa Emese, Tomkinson Birgitta
Department of Microbiology, The Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.
Biochim Biophys Acta. 2002 Dec 16;1601(2):149-54. doi: 10.1016/s1570-9639(02)00468-5.
Tripeptidyl-peptidase II (TPP II) is a 138-kDa subtilisin-like serine peptidase forming high molecular mass oligomers of >1000 kDa. The enzyme participates in general protein turnover and apoptotic pathways, and also has specific substrates such as neuropeptides. Here we report the site-directed mutagenesis of amino acids predicted to be involved in catalysis. The amino acids forming the putative catalytic triad (Asp-44, His-264, Ser-449) as well as the conserved Asn-362, potentially stabilizing the transition state, were replaced by alanine and the mutated cDNAs were transfected into human embryonic kidney (HEK) 293 cells. In clones stably expressing the mutant proteins, TPP II activity did not exceed the endogenous activity, thus confirming the essential role of the above amino acids in catalysis. Mutant and wild-type TPP II subunits co-eluted from a gel filtration column, suggesting that the subunits associate and that the native subunit conformation was retained in the mutants. Interestingly, the S449A and a H264A mutant enzyme affected the quaternary structure of the endogenously expressed TPP II, resulting in formation of an active, larger complex of >10,000 kDa.
三肽基肽酶II(TPP II)是一种138 kDa的枯草杆菌蛋白酶样丝氨酸肽酶,可形成分子量大于1000 kDa的高分子量寡聚体。该酶参与一般的蛋白质周转和凋亡途径,并且还有诸如神经肽等特定底物。在此我们报告对预测参与催化作用的氨基酸进行定点诱变。构成假定催化三联体(Asp-44、His-264、Ser-449)以及可能稳定过渡态的保守Asn-362的氨基酸被丙氨酸取代,并且将突变的cDNA转染到人胚肾(HEK)293细胞中。在稳定表达突变蛋白的克隆中,TPP II活性未超过内源性活性,从而证实了上述氨基酸在催化作用中的重要作用。突变型和野生型TPP II亚基从凝胶过滤柱中共同洗脱,表明亚基相互结合并且突变体中保留了天然亚基构象。有趣的是,S449A和H264A突变酶影响内源性表达的TPP II的四级结构,导致形成活性的、分子量大于10,000 kDa的更大复合物。